NCT06487637 CardioCare Quest: A Co-created Game for Improving Hypertension Treatment Compliance in Arizona
| NCT ID | NCT06487637 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northern Arizona University |
| Condition | High Blood Pressure |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-06-30 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-06-30 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims to address healthcare disparities among Navaho people diagnosed with hypertension or prehypertension through three main objectives. Firstly, it identifies and shares insights on healthcare access disparities affecting Navaho individuals experiencing nonadherence to hypertension treatment. Secondly, the proposal develops a telehealth solution based on factors identified as knowledge gaps caused by healthcare access disparities in hypertension management; we will use the factors to design a series of engaging minigames that can be incorporated into the larger CardioCare Quest. These minigames will be co-designed with end users and clinicians. Finally, the proposal conducts comprehensive qualitative and quantitative assessments of user experiences, perceptions, and challenges with CardioCare Quest.
Eligibility Criteria
Inclusion Criteria: * We are interested in interviewing people who receive, give, or are affected by HBP therapy. This includes medical professionals, patients with HBP between the ages of 18 and above, their family members, caretakers, and relevant community professionals such as social workers. * The project targets Urban Indigenous individuals in the patient category. A potential participant will be recognized as Urban Indigenous upon completing the registration form provided to them. * The project is interested in Navajo Nation groups that reside in Flagstaff. Exclusion Criteria: * Patients with uncontrolled or severely severe hypertension will be excluded from this study since controlling these instances may be the primary emphasis of the study rather than its intervention. * The exclusion will be based on considerations such as the severity of hypertension, the potential risks associated with uncontrolled hypertension, and the overall health status of the patient. * Participants having specific medical conditions that could interfere with or pose risks to the study's outcomes (e.g., severe heart disease, advanced kidney disease) will be excluded. * Pregnant women or those who want to get pregnant during the study period will be excluded due to the potential dangers to both the pregnant woman and the fetus.
Contact & Investigator
Tochukwu Ikwunne, PhD
PRINCIPAL INVESTIGATOR
Northern Arizona University
Frequently Asked Questions
Who can join the NCT06487637 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying High Blood Pressure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06487637 currently recruiting?
Yes, NCT06487637 is actively recruiting participants. Contact the research team at tochukwu.ikwunne@nau.edu for enrollment information.
Where is the NCT06487637 trial being conducted?
This trial is being conducted at Flagstaff, United States, Flagstaff, United States.
Who is sponsoring the NCT06487637 clinical trial?
NCT06487637 is sponsored by Northern Arizona University. The principal investigator is Tochukwu Ikwunne, PhD at Northern Arizona University. The trial plans to enroll 60 participants.